mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0001 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |